EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Homeopathy for knee osteoarthritis: Series of three randomized trials and statistical pooling of the results

Mousumi Koley, Shuvadip Ghosh, Chandrima Chatterjee, Rajat Kumar Pal, Subhasish Ganguly, Arpita Basu, Suhasish Roy, Shubhamoy Ghosh, Sangita Saha, Md Sakhawat Hossain, Sk Monsur Alam, Soumya Bhattacharyya, Saima Shamim, Pulakendu Bhattacharya, Satyajit Naskar, Pintu Debnath, Usashi Nag, Ankit Saha, Indrani Halder, Aryabrata Banerjee, Prosenjit Maji, Suchismita Sen, Junayed Akram, Priyanka Ghosh, Abdur Rahaman Shaikh, Debraj Mukherjee, Munmun Koley, Subhranil Saha, Kisor Kumar Naskar, Shyamal Kumar Mukherjee

Orthopaedic Journal of Madhya Pradesh Chapter · 2026

DOI: 10.4103/ojmpc.ojmpc_7_26 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Introduction: Despite its popularity, scientific research has so far not provided adequate support for homeopathy as a recommendable therapy in knee osteoarthritis (OA). Objective: To differentiate individualized homeopathic medicinal products (IHMPs) from identical-looking placebos in pain management of knee OA. Materials and Methods: Three-month, double-blind, randomized (1:1), parallel-arm, placebo-controlled trials were conducted consecutively on 266 patients with knee OA ( n = 134, 60, and 72). The participants received either verum (IHMPs plus concomitant care [CC]; n = 133) or control (identical-looking placebos plus CC; n =133). Different outcome measures were used: pain 0–10 Numeric Rating Scale (NRS), the Knee Injury and Osteoarthritis Outcome Scale (KOOS) and its subscales, the Measure Yourself Medical Outcome Profile, version 2.0, the EuroQol-5 Dimensions-5 Levels, transformed Western Ontario and McMaster Universities Arthritis Index score from KOOS, and frequency of add-on paracetamol and/or nonsteroidal anti-inflammatory drugs; all measured monthly for 3 months. The obtained results were combined statistically. Results: The results were nonsignificant in one of the trials (pain NRS: mean difference = 0.1, 95% confidence interval [CI]: −0.4 to 0.7; P = 0.655), whereas they were significant in other two; KOOS pain: mean difference = 7.8, 95% CI: 0.6–14.9; P = 0.034; and KOOS pain: mean difference = 11.5, 95% CI: 0.5–17.4; P < 0.001. Combined results were nonsignificant statistically ( P = 0.18), with substantial heterogeneity (I 2 = 84%). Conclusion: The null hypothesis of no difference could not be rejected; robust trials are warranted. Trial Registration: CTRI/2022/04/042070, CTRI/2022/04/041660, and CTRI/2020/10/028711.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →